Header image

Session 4C: From innovation to first-in-human trials: Practical guidance for using New Approach Methodologies (NAMs) in Australia

Tracks
Track 3
Wednesday, October 21, 2026
4:30 PM - 5:15 PM
Discovery & Advanced Therapeutics Breakout Room

Details

New Approach Methodologies (NAMs) are increasingly being used to strengthen translational confidence, reduce reliance on animal models and support safer progression into first-in-human trials. The next challenge is practical: how should NAM evidence be generated, presented, assessed and used by sponsors, Phase 1 sites, HRECs and regulators? Building on Bellberry and ASCEPT’s 2025 NAM Workshop 2 and double panel session at AusBiotech, this session will explore the practical application of Bellberry and ASCEPT guidance for the use of NAMs in first-in-human and early phase trials. The panel will bring together perspectives from a Phase 1 site, sponsor, technologist and the TGA to discuss what credible, consistent and useful NAM evidence looks like in practice.


Speaker

Agenda Item Image
Professor Carl Kirkpatrick
Professor
Monash University and ASCEPT Fellow

Panellist

Agenda Item Image
Dr. Michael Phelan
Principal Consultant
InnovApproach Consulting

Panellist

Agenda Item Image
Ms Kylie Sproston
CEO
Bellberry Limited

Chair

Agenda Item Image
Prof. Yi-Chin Toh
Professor
Queensland University Of Technology

Panellist

Agenda Item Image
Dr. George Vuckovic
Assistant Secretary
Scientific Evaluation Branch

Panellist

loading